# Axonex AI Group Limited (AXNX)

Source: https://www.quantisnow.com/company/AXNX
Generated: 2026-11-10T10:40:27.622Z

- Ticker: AXNX
- Exchange: NASDAQ
- Sector: Consumer Discretionary
- Industry: Business Services
- IPO year: 2018
- SEC CIK: 0001998560
- Website: https://www.mimintinc.com

## About

Axonex AI Group Limited (formerly Mint Incorporation Limited) (NASDAQ: AXNX) is a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider. Through its subsidiary, Axonex AI Limited, and its majority owned subsidiary, Rice Robotics AGI Holding Limited, the Group delivers robot models and robotics solutions, including the FLOKI Minibot M1 and micro-insurance solutions purpose-built for commercial robots. The Group also maintains its established interior design and fit-out works business. Anchored by its ongoing transformation, Axonex AI is focused on AI and robotics as its main growth driving engine.

## Latest AXNX news and filings

- 2026-10-20 15:43 UTC [Axonex AI Group Limited Announces 2-for-5 Reverse Stock Split](https://www.quantisnow.com/insight/axonex-ai-group-limited-announces-2-for-5-reverse-stock-split-6751897)
- 2026-10-15 12:30 UTC [Axonex AI Group Joins FLAIR’s Embodied AI International Applications Hub and Launches Education Humanoid TOMO](https://www.quantisnow.com/insight/axonex-ai-group-joins-flairs-embodied-ai-international-applications-hub-6747395)
- 2026-10-09 12:30 UTC [Axonex AI Group Limited (NASDAQ: AXNX)  Solidifies Transformation into an AI and Robotics-Focused Company](https://www.quantisnow.com/insight/axonex-ai-group-limited-nasdaq-axnx-solidifies-transformation-into-an-6742435)
- 2026-09-24 07:49 UTC [Public Offering] [CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors](https://www.quantisnow.com/insight/cairdac-announces-the-appointment-of-raymond-w-cohen-as-chairman-6724631)
- 2025-08-04 12:05 UTC [Public Offering] [RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors](https://www.quantisnow.com/insight/rxsight-inc-appoints-raymond-w-cohen-to-its-board-of-6144016)
- 2024-11-25 14:05 UTC [SEC Form 15-12G filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-axonics-inc-5789768)
- 2024-11-21 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-axonics-inc-5785810)
- 2024-11-15 19:23 UTC [SEC Form 25-NSE filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-axonics-inc-5778582)
- 2024-11-15 14:00 UTC [SEC Form 4] [Director Kiernan Jane E returned $1,410,131 worth of shares to the company (19,861 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-kiernan-jane-e-returned-1410131-worth-of-shares-to-5778320)
- 2024-11-15 14:00 UTC [SEC Form 4] [EVP, Chief Mktg/Strtgy Officer Woock John returned $5,495,613 worth of shares to the company (77,403 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/evp-chief-mktgstrtgy-officer-woock-john-returned-5495613-worth-of-5778318)
- 2024-11-15 14:00 UTC [SEC Form 4] [Director Snyderman Nancy Lynn Md returned $1,061,024 worth of shares to the company (14,944 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-snyderman-nancy-lynn-md-returned-1061024-worth-of-shares-5778316)
- 2024-11-15 13:59 UTC [SEC Form 4] [Chief Operating Officer Sama Rinda returned $5,996,802 worth of shares to the company (84,462 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-sama-rinda-returned-5996802-worth-of-shares-5778314)
- 2024-11-15 13:59 UTC [SEC Form 4] [Chief Medical Officer Noblett Karen returned $2,444,388 worth of shares to the company (34,428 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-noblett-karen-returned-2444388-worth-of-shares-5778312)
- 2024-11-15 13:59 UTC [SEC Form 4] [Director Lopez Esteban returned $468,600 worth of shares to the company (6,600 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-lopez-esteban-returned-468600-worth-of-shares-to-the-5778310)
- 2024-11-15 13:59 UTC [SEC Form 4] [Director Mcnamara Robert returned $1,055,131 worth of shares to the company (14,861 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-mcnamara-robert-returned-1055131-worth-of-shares-to-the-5778305)
- 2024-11-15 13:59 UTC [SEC Form 4] [Chief Commercial Officer Ford Alfred J Jr returned $3,084,950 worth of shares to the company (43,450 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-commercial-officer-ford-alfred-j-jr-returned-3084950-worth-5778293)
- 2024-11-15 13:59 UTC [SEC Form 4] [Chief Financial Officer Keese Kari Leigh returned $2,865,702 worth of shares to the company (40,362 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-keese-kari-leigh-returned-2865702-worth-of-5778291)
- 2024-11-15 13:59 UTC [SEC Form 4] [Director Demski David M returned $677,482 worth of shares to the company (9,542 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-demski-david-m-returned-677482-worth-of-shares-to-5778286)
- 2024-11-15 13:59 UTC [SEC Form 4] [Chief Executive Officer Cohen Raymond W returned $20,783,901 worth of shares to the company (292,731 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-cohen-raymond-w-returned-20783901-worth-of-5778285)
- 2024-11-15 13:58 UTC [SEC Form 4] [Director Carrel Michael H returned $1,268,131 worth of shares to the company (17,861 units at $71.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-carrel-michael-h-returned-1268131-worth-of-shares-to-5778284)
- 2024-11-15 13:58 UTC [SEC Form POS AM filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-axonics-inc-5778282)
- 2024-11-15 13:56 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-axonics-inc-5778281)
- 2024-11-15 13:55 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-axonics-inc-5778280)
- 2024-11-15 13:54 UTC [SEC Form 8-K] [Axonics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/axonics-inc-filed-sec-form-8-k-completion-of-acquisition-or-5778278)
- 2024-11-15 13:43 UTC [Boston Scientific Closes Acquisition of Axonics, Inc.](https://www.quantisnow.com/insight/boston-scientific-closes-acquisition-of-axonics-inc-5778266)
- 2024-11-13 00:01 UTC [SEC Form 4] [Director Snyderman Nancy Lynn Md gifted 5,000 shares, decreasing direct ownership by 25% to 14,944 units (SEC Form 4)](https://www.quantisnow.com/insight/director-snyderman-nancy-lynn-md-gifted-5000-shares-decreasing-direct-5769432)
- 2024-11-07 21:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-axonics-inc-5759220)
- 2024-11-07 21:03 UTC [SEC Form 8-K] [Axonics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/axonics-inc-filed-sec-form-8-k-results-of-operations-and-5758855)
- 2024-11-07 21:01 UTC [Axonics Reports Third Quarter 2024 Financial Results](https://www.quantisnow.com/insight/axonics-reports-third-quarter-2024-financial-results-5758764)
- 2024-10-03 23:25 UTC [SEC Form 4] [Chief Financial Officer Keese Kari Leigh sold $205,512 worth of shares (2,961 units at $69.41), decreasing direct ownership by 7% to 40,362 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-keese-kari-leigh-sold-205512-worth-of-5716215)
- 2024-09-26 10:00 UTC [Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia](https://www.quantisnow.com/insight/axonics-receives-regulatory-approval-for-fourth-generation-rechargeable-snm-system-in-5705144)
- 2024-09-18 22:59 UTC [Axonics Prevails in Patent Infringement Lawsuit with Medtronic](https://www.quantisnow.com/insight/axonics-prevails-in-patent-infringement-lawsuit-with-medtronic-5698700)
- 2024-08-01 20:07 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Axonics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-axonics-inc-5638176)
- 2024-08-01 20:03 UTC [SEC Form 8-K] [Axonics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/axonics-inc-filed-sec-form-8-k-results-of-operations-and-5637960)
- 2024-08-01 20:01 UTC [Axonics Reports Second Quarter 2024 Financial Results](https://www.quantisnow.com/insight/axonics-reports-second-quarter-2024-financial-results-5637904)
- 2024-07-25 23:33 UTC [SEC Form 4] [Chief Executive Officer Cohen Raymond W exercised 103,896 shares at a strike of $22.94, increasing direct ownership by 55% to 292,731 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-cohen-raymond-w-exercised-103896-shares-at-5629049)
- 2024-07-25 12:00 UTC [Leadership Update] [Kestra Medical Technologies Announces Appointment of Veteran Medical Device Executive, Raymond W. Cohen, to its Board of Directors](https://www.quantisnow.com/insight/kestra-medical-technologies-announces-appointment-of-veteran-medical-device-executive-5627160)
- 2024-05-16 20:07 UTC [Market Chatter] [Axonics Receives Approval From The Therapeutic Goods Administration For Marketing Of Axonics F15 In Australia](https://www.quantisnow.com/insight/axonics-receives-approval-from-the-therapeutic-goods-administration-for-marketing-5497137)
- 2024-05-16 20:01 UTC [Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia](https://www.quantisnow.com/insight/axonics-receives-regulatory-approval-for-recharge-free-snm-system-in-australia-5496947)
- 2024-05-06 14:10 UTC [Market Chatter] [Needham Reiterates Hold on Axonics](https://www.quantisnow.com/insight/needham-reiterates-hold-on-axonics-5461481)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AXNX
- Earnings history: https://www.quantisnow.com/earnings/AXNX
- Dividend history: https://www.quantisnow.com/dividends/AXNX
- Insider transactions: https://www.quantisnow.com/insiders/AXNX
- Options chain: https://www.quantisnow.com/options/AXNX
- SEC 8-K filings only: https://www.quantisnow.com/company/AXNX/8-k
- RSS and alerts for AXNX: https://www.quantisnow.com/docs/rss-feeds.md